FDA Releases New Guidelines on Scientific Literature Used for Promotional Purposes


The FDA has released a new checklist meant to clarify the ways a pharmaceutical manufacturer may use scientific and medical literature to promote products.  The checklist constitute a revision of 2009 guidelines that were criticized for restricting companies’ ability to “promote the public health.”  The new guidelines call for an emphasis on science, not promotion, and also recommends that literature not be funded – either in whole or in part – or distributed by a company.

FDA Guidelines →

Of further interest:
FDA Releases Guidance on Use of Scientific and Medical Literature for Promotional Purposes (Regulatory Focus)

Previous articleRob Wipond – Short Bio
Next article“Andrew Solomon, Poster Child for Psychiatric Misdiagnosis”
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].